Immunotherapy toxicity: identification and management O. GumusayJ. CallanH. S. Rugo Review Open access 11 January 2022 Pages: 1 - 17
Low RUFY3 expression level is associated with lymph node metastasis in older women with invasive breast cancer Fernando A. AngaritaMasanori OshiKazuaki Takabe Preclinical study 12 January 2022 Pages: 19 - 32
PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy Yu FanGuiqin XieXiaorong Zhong Preclinical study Open access 03 January 2022 Pages: 33 - 42
Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes Ana Carolina PavanelliFlavia Rotea MangoneMaria Aparecida Nagai Preclinical study 15 January 2022 Pages: 43 - 52
The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth Yayun LiangCynthia Besch-WillifordSalman M. Hyder Preclinical study 17 January 2022 Pages: 53 - 63
Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA) Carlo MorassoAlessandra RicciardiFabio Corsi Preclinical study Open access 21 December 2021 Pages: 65 - 74
Polarity protein Par3 sensitizes breast cancer to paclitaxel by promoting cell cycle arrest Yannan ZhaoHuitong PengShe Chen Preclinical study 26 January 2022 Pages: 75 - 87
A novel long non-coding RNA regulates the integrin, ITGA2 in breast cancer Tristan Joseph VerhoeffAdele F. HollowayJoanne L. Dickinson Preclinical study 31 January 2022 Pages: 89 - 100
Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching Nalee KimHaeyoung KimTae Gyu Kim Clinical trial 16 January 2022 Pages: 101 - 112
Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer Jessica A. MartinezBetsy C. WertheimPatricia A. Thompson Clinical trial 18 January 2022 Pages: 113 - 122
A retrospective study evaluating the impact of scattering radiation from imaging procedures on oocyte quality during ovarian stimulation for fertility preservation in young breast cancer patients Margherita CondorelliMaëlle SensIsabelle Demeestere Clinical trial 18 January 2022 Pages: 123 - 130
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer Kritika YadavJoline LimSoo Chin Lee Clinical trial Open access 20 December 2021 Pages: 131 - 142
Chemotherapy for ipsilateral breast tumor recurrence: a propensity score-matching study Soo Yeon BaekJisun KimSae Byul Lee Clinical trial 30 January 2022 Pages: 143 - 152
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer Patricia A. GanzHanna BandosNorman Wolmark Clinical trial 03 February 2022 Pages: 153 - 161
Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer Genevieve A. FasanoSolange BayardLisa Newman Epidemiology 13 January 2022 Pages: 163 - 173
Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation B. B. M. SuelmannC. F. J. BakhuisP. J. van Diest Epidemiology 18 January 2022 Pages: 175 - 189
Racial and socioeconomic disparities in breast cancer diagnosis and mortality in Pennsylvania Austin D. WilliamsMeghan BuckleyNed Z. Carp Epidemiology 22 January 2022 Pages: 191 - 200
Perceptions of patients and medical oncologists toward biospecimen donation in the setting of abnormal breast imaging findings Davinia S. SeahNabihah TayobNancy U. Lin Epidemiology 23 January 2022 Pages: 201 - 210
Influence of rurality on lymph node assessment among women diagnosed with ductal carcinoma in situ and treated with mastectomy, SEER 2000–2015 Danielle RileyElizabeth A. ChrischillesCharles F. Lynch Epidemiology 24 January 2022 Pages: 211 - 222
Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy Danielle RodinRinku SutradharEileen Rakovitch Epidemiology 27 January 2022 Pages: 223 - 233
